VolitionRx Limited and Veterinary Pathology Group (VPG) joined forces to launch the Nu.Q(R) Vet Cancer Test to veterinary practices in the UK and Ireland. VPG is the first-to-market diagnostic laboratory in the UK and Ireland to offer the Nu.Q Vet Cancer Test, a tool for the early detection and monitoring of cancer in dogs. Volition's Nu.Q(R) Pet Cancer Test is an accessible and affordable screening tool for dogs with increased risk of developing cancer, such as older dogs, certain breeds with higher cancer prevalence rates and those dogs with familial history.

It is a simple, non-invasive blood test that can easily integrate into preventive care plans. Veterinaryarians can run the test alongside routine blood work and imaging, to help provide earlier cancer detection, improve a dog's quality of life and give a better chance of effective treatment.